The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect?
Abstract
Recent reports highlight the utility of in vivo magnetic resonance spectroscopy (MRS) techniques to recognize creatine deficiency syndromes affecting the central nervous system (CNS). Reported cases demonstrate partial reversibility of neurologic symptoms upon restoration of CNS creatine levels with the administration of oral creatine. We describe a patient with a brain creatine deficiency syndrome detected by proton MRS that differs from published reports. Metabolic screening revealed elevated creatine in the serum and urine, with normal levels of guanidino acetic acid. Unlike the case with other reported creatine deficiency syndromes, treatment with oral creatine monohydrate demonstrated no observable increase in brain creatine with proton MRS and no improvement in clinical symptoms. In this study, we report a novel brain creatine deficiency syndrome most likely representing a creatine transporter defect. Ann Neurol 2001;49:401–404
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Guanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
Cited by
X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Self-citationIn vivo magnetic resonance spectroscopy: basic methodology and clinical applications
van der Graaf, M. (2010) · European Biophysics Journal · doi:10.1007/s00249-009-0517-y · Cited by 275
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Item, C. B., Stöckler-Ipsiroglu, S., Stromberger, C., Mühl, A., Alessandrì, M. G., Bianchi, M. C., Tosetti, M., Fornai, F., & Cioni, G. (2001) · The American Journal of Human Genetics · doi:10.1086/323765 · Cited by 233
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
Cerebral creatine deficiency syndromes: Clinical aspects, treatment and pathophysiology
Stockler, S., Schutz, P. W., & Salomons, G. S. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_8 · Cited by 180
Phenotype and genotype in 101 males with X-linked creatine transporter deficiency
van de Kamp, J. M., Betsalel, O. T., Mercimek-Mahmutoglu, S., Abulhoul, L., Grünewald, S., Anselm, I., Azzouz, H., Bratkovic, D., de Brouwer, A., Hamel, B., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101658 · Cited by 164
Self-citationCreatine deficiency syndromes and the importance of creatine synthesis in the brain
Braissant, O., Henry, H., Béard, E., & Uldry, J. (2011) · Amino Acids · doi:10.1007/s00726-011-0852-z · Cited by 145
Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59373 · Cited by 98
Self-citationHanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes
Clark, J. F., & Cecil, K. M. (2015) · Pediatric Research · doi:10.1038/pr.2014.203 · Cited by 61
Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect
van de Kamp, J. M., Pouwels, P. J. W., Aarsen, F. K., ten Hoopen, L. W., Knol, D. L., de Klerk, J. B., de Coo, I. F., Huijmans, J. G. M., Jakobs, C., van der Knaap, M. S., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9345-1 · Cited by 59
Self-citationTrotier-Faurion, A., Dézard, S., Taran, F., Valayannopoulos, V., de Lonlay, P., & Mabondzo, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400545n · Cited by 36
Metadata
- Authors
- Cecil, K. M., Salomons, G. S., Ball, W. S., Wong, B., Chuck, G., Verhoeven, N. M., Jakobs, C., & DeGrauw, T. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 49
- Issue
- 3
- Pages
- 401-404
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2090015966
- Cited by
- 181
- References
- 5
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.